Agios Pharmaceuticals
AGIO
AGIO
154 hedge funds and large institutions have $1.3B invested in Agios Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 61 increasing their positions, 47 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
23% less capital invested
Capital invested by funds: $1.7B → $1.3B (-$396M)
47% less call options, than puts
Call options by funds: $4.27M | Put options by funds: $8.04M
Holders
154
Holding in Top 10
–
Calls
$4.27M
Puts
$8.04M
Top Buyers
| 1 | +$25.4M | |
| 2 | +$9.59M | |
| 3 | +$9.12M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$8.36M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$7.37M |
Top Sellers
| 1 | -$41.7M | |
| 2 | -$41.4M | |
| 3 | -$28.9M | |
| 4 |
BlackRock
New York
|
-$8.07M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.43M |